174 related articles for article (PubMed ID: 27889768)
1. Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy Among Patients with Diabetes Mellitus: a Meta-Analysis.
Zhou B; Zou H; Xu G
Kidney Blood Press Res; 2016; 41(6):919-928. PubMed ID: 27889768
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis.
Liao X; Zhu Y; Xue C
BMC Endocr Disord; 2022 Jun; 22(1):149. PubMed ID: 35655297
[TBL] [Abstract][Full Text] [Related]
3. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
[TBL] [Abstract][Full Text] [Related]
4. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?
El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella N; George S
Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Serum Cystatin C for the Evaluation of Renal Dysfunction in Diabetic Patients: A Meta-Analysis.
Yang SK; Liu J; Zhang XM; Hu C; Zhang W; Sun L; Zhang H
Ther Apher Dial; 2016 Dec; 20(6):579-587. PubMed ID: 27921376
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
[TBL] [Abstract][Full Text] [Related]
8. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies.
Li Y; Su X; Ye Q; Guo X; Xu B; Guan T; Chen A
Ren Fail; 2021 Dec; 43(1):231-240. PubMed ID: 33478336
[TBL] [Abstract][Full Text] [Related]
10. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis.
He F; Xia X; Wu XF; Yu XQ; Huang FX
Diabetologia; 2013 Mar; 56(3):457-66. PubMed ID: 23232641
[TBL] [Abstract][Full Text] [Related]
11. Serum cystatin C as an early marker of nephropathy among type 2 diabetics: A meta-analysis.
Arceo ES; Dizon GA; Tiongco REG
Diabetes Metab Syndr; 2019; 13(6):3093-3097. PubMed ID: 31778883
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Retinopathy in the Detection of Diabetic Nephropathy in Type 2 Diabetes: A Systematic Review and Meta-Analysis of 45 Studies.
Jiang S; Yu T; Zhang Z; Wang Y; Fang J; Yang Y; Liu L; Li W
Ophthalmic Res; 2019; 62(2):68-79. PubMed ID: 31256153
[TBL] [Abstract][Full Text] [Related]
13. Clinical Implication of Cystatin C and β2-Microglobulin in Early Detection of Diabetic Nephropathy.
Chen H; Li H
Clin Lab; 2017 Feb; 63(2):241-247. PubMed ID: 28182344
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
15. Serum Cystatin C as an Early Diagnostic Biomarker of Diabetic Kidney Disease in Type 2 Diabetic Patients.
Qamar A; Hayat A; Ahmad TM; Khan A; Hasnat MNU; Tahir S
J Coll Physicians Surg Pak; 2018 Apr; 28(4):288-291. PubMed ID: 29615169
[TBL] [Abstract][Full Text] [Related]
16. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Elsayed MS; El Badawy A; Ahmed A; Omar R; Mohamed A
Diabetes Metab Syndr; 2019; 13(1):374-381. PubMed ID: 30641728
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C for early detection of renal impairment in diabetes.
Willems D; Wolff F; Mekahli F; Gillet C
Clin Biochem; 2009 Jan; 42(1-2):108-10. PubMed ID: 18983837
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
[TBL] [Abstract][Full Text] [Related]
19. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
20. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
Liu Q; Wang M; Xu T; Liang W; Yang F
J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
